Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy - Wikidata - awgldk - TriplyDB

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy

http://www.wikidata.org/entity/Q35120228

about

Contralateral prophylactic mastectomy: current perspectives Cost of contralateral prophylactic mastectomy Breast cancer in young women: special considerations in multidisciplinary care.Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.Factors associated with contralateral preventive mastectomy Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy Triple-negative breast cancer is not a contraindication for breast conservation.Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.Knowledge, attitude and practice of prophylactic mastectomy among patients and relations attending a surgical outpatient clinic.Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy.Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.Decision making for breast cancer prevention among women at elevated risk Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?Prophylactic mastectomy: who needs it, when and why.Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.Differences between Breast Conservation-Eligible Patients and Unilateral Mastectomy Patients in Choosing Contralateral Prophylactic Mastectomies.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer.Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis

P2860

Q26744320-51609130-17BB-451C-8236-7FB89F0C19C1 Q34017128-62F4F09F-66F2-44DF-8AFF-BE28ACD168D2 Q34306522-185A0FEE-EB1E-4ED4-A7C8-BD10FC9F80F9 Q34343656-4F243E56-7C62-4324-A0D7-949194FB0B50 Q34471501-F37FDFB5-E505-4E5B-AC55-0136A8ACACAF Q34943336-06E401FC-D180-4BBB-BA11-A1EACCD8B658 Q35073191-16487200-FA5C-4A40-838A-688D583E69A5 Q35111687-202D7703-7E69-4392-8313-BB718A1BCC09 Q35192288-1E4A0284-3484-42D4-BA3D-07C5962FF291 Q35584662-5DCA46E3-CF74-43DD-A792-46319D1980CA Q35634061-24DD2079-516F-4407-B409-27FBDE23C23B Q35838312-CB722AF8-BD5C-45E3-A8F5-E060438B094E Q35925651-F7BB3ECA-A23D-4CC8-8BB9-D3B452B05C57 Q36137506-2B323197-6DB3-4A15-9205-13355B37524E Q36265582-EAADDFB5-AEA6-4A1D-8853-C2B8C17BF639 Q36339415-17433CBB-E4BA-4582-A5A5-ED21E55EA275 Q36436637-E7A7A268-5BB2-401D-A7ED-8F52C3300BEC Q36479848-200CB777-9252-4E17-8C90-53D217E642E2 Q36770162-98C916BB-CD86-4F97-8654-CE4C347E51EB Q37267678-12B962A5-9E32-43DB-B9B1-B9845A4A58CD Q37387444-00CF6D42-B6B8-4AAF-A1F3-F8FDABD8A770 Q37594381-EEE6CFEA-D9AB-475B-AFA0-013C15897588 Q37609525-F7D8942D-3E75-46C6-B2A7-B56974676F73 Q37669779-1F777E41-98B1-4BC7-AF61-DA6121A18FA2 Q37720955-F46A5A7C-7727-46FF-8DA5-2EE37DBE9210 Q38188901-963BABC9-A209-4686-9B6F-2A7B02EE85C8 Q38223259-2C4D4D1F-0A95-4B14-B852-BF164406BC4C Q38399448-08AAD4F6-8226-49FF-A38A-241597925408 Q38738100-9213E1DF-51FB-4316-8913-55176FC111A2 Q38846562-1103FB64-F838-492C-85BF-0EDD348E1015 Q38937870-110EEC94-E4B1-4B38-A621-287BF5B1306F Q39033804-83CDC05B-9C4D-4163-BACE-5CC5B075811E Q39077474-F67D2874-8737-427B-9142-52E2499E94E5 Q39103033-3E3A90F8-226B-42C8-9272-2F8BE1CBFD23 Q40043241-7E4E06BC-6A3C-40FA-9C03-DB18C48AE775 Q40098508-9FE0ED54-CE95-4DE6-8290-BB0E47FFC586 Q40393469-2DB485BF-A079-443A-897E-383DEACD4B00 Q40758851-DE2578E3-C41B-4DAF-AA06-E749D5A3DBA2 Q41088085-E1963BCA-F45C-4B7F-8C66-A50D69440DFF Q41146968-7D6E6B02-B6F4-4A91-B15B-A6E0C0E4996C

P2860

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy

http://www.wikidata.org/entity/Q35120228

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Factors affecting the decision ...... ateral prophylactic mastectomy

@ast

Factors affecting the decision ...... ateral prophylactic mastectomy

@en

type

label

Factors affecting the decision ...... ateral prophylactic mastectomy

@ast

Factors affecting the decision ...... ateral prophylactic mastectomy

@en

prefLabel

Factors affecting the decision ...... ateral prophylactic mastectomy

@ast

Factors affecting the decision ...... ateral prophylactic mastectomy

@en

P1433

Q35120228-EE10D60A-17D8-43FE-92CE-EEF78DAF8269

P1476

Q35120228-FAA35C0B-F8D5-4315-8430-42CF36ED99D0

P2093

Q35120228-03F8FFE7-9425-4283-ABFB-687FC9B2F36F

Q35120228-19E7EE01-0CE1-449E-B388-B1B4E1CA860E

Q35120228-5C9C1C95-0200-4A3F-A2A7-934352DBFB95

Q35120228-7E47AAD7-80AD-4B73-85A2-46D6D546C0B8

Q35120228-85C67476-C2DB-40C5-AE96-79E367B50600

Q35120228-8682636A-3F9D-4122-BBE2-1A1F40C96342

Q35120228-8A6B842C-2318-42C8-9726-2E933BF5438E

Q35120228-A67DFE00-01DF-48D4-A369-72A3884286AC

Q35120228-A998CAC0-37B7-40C8-8450-76C1C37BFB5E

Q35120228-B1A37709-C65B-42E4-B807-0041F37A8901

P2860

Q35120228-12C14DAA-2310-4664-A240-2EDEE4CB2F94

Q35120228-2778EFB8-0034-4BEA-8DC4-3BCC7BB009CB

Q35120228-33D7F89F-38D8-437C-B3A3-E4C40CC2202C

Q35120228-6E215B16-A565-4C97-8E2F-6414AA826B02

Q35120228-77A7F0B7-E430-4CF5-893A-6450A820977A

Q35120228-79F48B2C-DD55-49BB-9C43-C945662C8B0A

Q35120228-7F9DE3EA-A510-4CAF-A9E1-96C16563B808

Q35120228-82D7D001-8D24-4CEF-B741-6163C303AE68

Q35120228-834B99C6-5562-4093-B70B-C10B6F458D0F

Q35120228-8C12E0A8-2FBC-4470-BBE0-8C2657D68899

P304

Q35120228-4055294E-C6F7-45CD-80A9-4402DD124C18

P31

Q35120228-8AE140B7-076E-4538-927E-DB199C215AD1

P356

Q35120228-64E9B4E8-56E5-4091-BEAA-96A84E27B761

P433

Q35120228-ED1025E5-ACFD-4A60-9E7F-877A9E2FC04C

P478

Q35120228-41BE96E7-B187-4F84-BF78-6221E7BD24D6

P50

Q35120228-CCECA07E-FCC8-4AAF-9301-BB5F8F890626

P577

Q35120228-5CFF3662-0E09-48E9-83FE-5D267AA297B3

P698

Q35120228-A5072F02-4354-41BF-8D4D-757F8DCE903D

P932

Q35120228-060645C3-99AF-4D8E-AF39-06775C07CAEE

P356

1940-6207.CAPR-09-0130

P1433

Cancer Prevention Research

P1476

Factors affecting the decision ...... ateral prophylactic mastectomy

@en

P2093

Angelica Gutierrez Barrera

http://www.w3.org/2001/XMLSchema#string

Banu K Arun

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Mittendorf

http://www.w3.org/2001/XMLSchema#string

Gildy V Babiera

http://www.w3.org/2001/XMLSchema#string

Henry M Kuerer

http://www.w3.org/2001/XMLSchema#string

Isabelle Bedrosian

http://www.w3.org/2001/XMLSchema#string

Jennifer Litton

http://www.w3.org/2001/XMLSchema#string

Kaylene Ready

http://www.w3.org/2001/XMLSchema#string

Kelly K Hunt

http://www.w3.org/2001/XMLSchema#string

Kim-Anh Do

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

MRI of occult breast carcinoma in a high-risk population.

Contralateral prophylactic mastectomy. Predictors of significant histologic findings.

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.

Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

P304

1026-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-09-0130

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Funda Meric-Bernstam

P577

2010-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20647335

http://www.w3.org/2001/XMLSchema#string

P932

4340054

http://www.w3.org/2001/XMLSchema#string